I believe in Renewable Energy, and here's why

Renewable energy (RE) is a subjective and divisive topic, one that is influenced by many factors, including corruption, greed and purposeful ignorance, scientific and technological advances, and simple entrepreneurial spirit vs. entrenched interests.

Here are some of the reasons that I believe that we will see RE replace old energy by the midpoint of this century:

* It has been estimated that an area 55 miles by 55 miles dedicated to current solar technologies could replace all the electrical generating power of coal and oil (in the US). Or an area 80x80 miles to replace oil, coal and natural gas. (Here in the US we have over 100,000 square miles of desert, so space isn’t a problem)

* Regarding storage technologies (1) for when the sun is down: consider the advances taking place in fuel cells, batteries (LI, redox flow batteries, and 1300-ton battery modules used for grid stabilization), flywheels, compressed air, ultracapacitors and the likelihood that we will also use battery powered vehicles as storage.

* Regarding “getting the power from the solar installation to the people” – consider advances in superconducting wire and other advanced materials which are very likely to enable cheap and efficient transmission of power from where ever it is generated to where ever it is needed.

* Rooftop and local solar: My solar powered home won’t have to worry about darkness; we’ll tap into the battery reserve, as will all rooftop solar installations. A small percentage of our overall use to be sure, but significant none the less.

And as for explicit subsidies: on a per-energy-unit basis, then yes, solar has received more subsidies than fossil fuels in the very recent past. However, on the amount that each of us taxpayers has spent in a recent five-year period, fossil fuels subsidies far exceed solar.

Estimates range: (2)

Coal subsidies = somewhere between $17B and $72B
Solar subsidies = somewhere between $500M and $5B

And let us not forget that coal subsidizes also include intangible (and often purposefully left out) costs for cleaning up the ecosystem, and the public health expenses associated with all of the damage that the mining and use of coal causes. (3)

In my opinion, at the end of the day it all boils down to two simple facts: 1) technological change is on a double exponential growth curve (4) and 2) simple entrepreneurial spirit.

While we certainly need to wean society off finite, dangerous, polluting resources like coal and oil, the earth can and may go to hell in a handbasket. However, I think that entrepreneurial spirit and the certain fact that there is a barrel of money to be made in renewable energy solutions suggests that we will see RE replace old energy by the midpoint of this century. (5)

(1) "Of the ten advanced energy storage technologies, eight have applications in storage for electric power utilities at some level of development, aiming to provide reliable, economic, and energy-efficient power back-up options." Technical Insights Analyst Miriam Nagel

A123 Systems currently sells 2MW to 200MW grid stabilization systems (battery systems). Being used for large-scale energy storage deployment to support wind and solar integration. Small in comparison to the overall needs, but just one of many rapidly improving technologies.

“If investments in the smart grid infrastructure continue, electric vehicles may become ubiquitous — both because of the economic and environmental sense they make for consumers, and because of the vast store of batteries that will be available to grid operators to balance out the intermittency of wind and solar resources.”

“There are several major studies and research showing how the United States could reach 100 percent renewable electricity by 2050. Over the next two decades, the continually rising costs of fossil fuels will make it prohibitive to continue burning them, so we’ll witness the overdue transition to a largely renewable system. Smart grid upgrades will feature two-way communication to consumer appliances, real-time pricing information, more efficient transmission infrastructure, and advanced battery and flywheel technologies to balance the inherent fluctuations of wind and solar resources.”

http://www.mnn.com/earth-matters/energy/blogs/quayle-hodek-a-young-ceo-running-with-the-wind?hpt=Sbin

(2) “What if solar got the same subsidies as coal?” (Oct 21, 2010)
http://cleantechnica.com/2010/10/21/what-if-solar-got-the-same-subsidies-as-coal/

Coal subsidies: The U.S. coal industry enjoyed subsidies of around $17 billion between 2002 and 2008, including tax credits for production of "nonconventional" fuels ($14.1 billion), tax breaks on coal royalties ($986 million), exploration, and development breaks ($342 million), according to a study by the Environmental Law Institute.

http://sierraclub.typepad.com/mrgreen/2010/03/does-the-coal-industry-get-subsidies.html

Solar and wind subsidies: So far, the government has handed out about $5.4 billion, according to the Energy Department.

http://money.cnn.com/2010/11/18/news/economy/renewable_energy_tax_credit/index.htm

(3) Very informative investigative article http://wonkroom.thinkprogress.org/2011/02/03/manchin-coal-subsidies/

(4) “Most long range forecasts of technical feasibility in future time periods dramatically underestimate the power of future technology because they are based on what I call the “intuitive linear” view of technological progress rather than the “historical exponential view.” To express this another way, it is not the case that we will experience a hundred years of progress in the twenty-first century; rather we will witness on the order of twenty thousand years of progress (at today’s rate of progress, that is).” Ray Kurzweil http://www.kurzweilai.net/the-law-of-accelerating-returns

(5) During the past 11 years, as the editor of the leading nanoscale technologies web portal, I read and posted over 50,000 articles about advanced and frequently mind-blowing technologies. I have closely followed the very rapid progress in our understanding and utilization of the unique properties of the nanoscale (which greatly differ from the properties that we already understand). At the very least, we are headed for a future that not one of us can predict; what we can predict is that we will undoubtedly see old myths about technologies shattered and changes beyond our current level of comprehension.

Shantanu Sur Receives Tenure and Promotion to Associate Professor at Clarkson University – Clarkson University News

Prof. Shantanu Sur

Clarkson University President Tony Collins has announced that Shantanu Sur has been granted tenure and promoted from assistant professor to associate professor of biology in the School of Arts and Sciences.

A neuroscientist by training and working on the design of neural scaffolds and regeneration, Shantanu has expanded his research at Clarkson from studying airborne pathogens to build mathematical models for disease prediction. His recent work focuses on understanding the interactions between cancer cells and supramolecular biomaterials to identify supramolecular design principles that can induce regulated cell death. He is also collaborating with faculty from the Mathematics Department to develop a model of cancer cell movement to better understand the invasive behavior of cancer cells.

Shantanu has developed an extensive collaboration with the Canton-Potsdam Hospital to explore the possibilities of real-world applications of his research. He is working closely with Dr. Suresh Dhaniyala, Professor of Mechanical and Aeronautical Engineering, towards the detection and monitoring of pathogens causing healthcare-associated infections (HAIs) by using a network of portable, field-deployable sensors. In a different direction, he is working with Dr. Sumona Mondal, Professor of Mathematics and Dr. Eyal Kedar, Rheumatologist at the Canton-Potsdam Hospital to develop predictive models to aid in the diagnosis and prognosis of rheumatoid arthritis in a rural setting.

He has authored or co-authored more than twenty peer-reviewed publications and two book chapters, which include publications in prestigious journals such as Nature Communications, Nano Letters, ACS Nano, Angewandte Chemie, and Biomaterials. His research has been supported through external funding agencies such as NSF, NYSDEC, and HTR NEXUS-NY.

At Clarkson, he teaches courses in the area of clinical and health sciences. In addition to serving the Biology Department, he has been teaching core courses in the Department of Physical Therapy and the Department of Occupational Therapy. Two graduate students mentored by him received the prestigious NSF Graduate Research Fellowship.

Shantanu is a trained physician, completed his Bachelors in Medicine and Surgery from N.R.S. Medical College, University of Calcutta. He received his Masters in Medical Science and Technology and Ph.D. from the School of Medical Science and Technology, Indian Institute of Technology Kharagpur. Before joining Clarkson, he worked as a research scientist at the Brain Science Institute, RIKEN and a postdoctoral fellow at the Institute for BioNanotechnology in Medicine, Northwestern University.

Read the rest here:
Shantanu Sur Receives Tenure and Promotion to Associate Professor at Clarkson University - Clarkson University News

Out of Touch: Depletion of Mechanosensors Drives Wound-Healing and Cancer – TMC News – Texas Medical Center News

Additional dates:Next Event:February 11, 2020

Dr. Michael SheetzWelch Professor of BiochemistryMolecular MechanoMedicine ProgramBiochemistry and Molecular BiologyUniversity of Texas Medical BranchGalveston, TX

Out of Touch: Depletion of Mechanosensors Drives Wound-Healing and Cancer

Tuesday, February 11, 202012:30 1:30 PMBRC, 10th Floor, Room 1060 A/B

Abstract: Loss of matrix rigidity sensing in tumor cells enables transformed growth. In over forty tumor lines tested, they lack rigidity sensing complexes because components are altered (about 60% had low Tpm 2.1). The rigidity sensing complex (about 2 m in length) contracts matrix adhesions by ~100nm; and if the force generated is greater than ~25 pN, then cells can grow (Wolfenson et al., 2016. Nat Cell Bio. 18:33). However, if the surface is soft, then the cells apoptose by DAPK1 activation (Qin et al., 2018 BioRxiv. 320739). Although tumor cells grow on soft surfaces, restoration of rigidity sensing restores rigidity-dependent growth (Yang, B. et al., 2020 Nature Mat. 19: 239). Surprisingly, mechanical stretch of transformed cancer cells activates apoptosis through calpain-dependent apoptosis (Tijore et al., 2018 BioRxiv. 491746). Thus, stretch sensitivity is a weakness of cancer cells related to transformation and not to the tissue type or other factors.

Bio: Prof. Michael Sheetz has a long history in mechanobiological research and was most recently the Director of the Mechanobiology Institute at the National University of Singapore. Prior to that he was a Professor at Columbia University where he headed a program in nanomedicine. At Duke University Medical School, he was Chair of Cell Biology from 1990 to 2000. He has received many awards including the Lasker Prize, Wiley and Massry Prizes.

Visit link:
Out of Touch: Depletion of Mechanosensors Drives Wound-Healing and Cancer - TMC News - Texas Medical Center News

What are the Upcoming Trends of Nanotechnology in Medicine? – Medical Tech Outlook

Nanotechnology is a rapidly expanding area of research with massive potential in many sectors ranging from healthcare to construction, and electronics.

FREMONT, CA: In the field of medicine, nanotechnology has revolutionized drug delivery, gene therapy, diagnostics, and various other areas of research, development and clinical application. Nanotechnology is a leading technology in medicine, bettering the potential of nanotechnology to target specific cells or tissues is a popular area of interest for the companies producing nanomedicines. Numerous registered clinical trials are in progress and involve nanotechnology; many of these studies are related to oncology and other therapy areas such as autoimmune diseases, anti-fungal agents and rare diseases. Playing a significant role in the transformation of medicine, identifying the trends in nanotechnology industry is essential.

Target Specification

The area of medicinal research involves attaching nanoparticles into drugs or liposomes to enhance specific localization. Different cell types have remarkable properties, and nanotechnology can be used to recognize cells of interest. This method enables associated drugs and therapeutics to reach diseased tissue while bypassing healthy cells.

Controlled Drug Release

The capability to control the discharge of a drug or therapeutic compound from its associated nanotechnology is benefitting a lot of interest from the industry. This triggered release can be gained from inside the body or from outside the body. The internal system consists of changes in the ecosystem of tumours in comparison with the surrounding tissues, while external stimuli comprise temperature change, ultrasound, or light. At present, the research efforts are dedicated to trying to understand how to release diagnostic molecules and drugs from liposomes with heat, and microbubbles using ultrasound.

Understanding Varied Patient Populations

Generally, there is a need for a better understanding of what makes patients distinctive from each other in terms of lack of ubiquitous drug efficacy. This raises a question, why nanotechnologies are not always able to improve the therapeutic output of drugs for an individual patient. Understanding the behaviour of nanomedicines when encountering different physiological characteristics of the patients and their disease states is significant.

Production of Nanomedicine

When compared to standard drug compounds, synthesizing and producing nanomedicine is primarily believed to be more complicated. In a few cases, this can limit the potential of drug manufacturers or pharmaceutical companies to deliver large quantities of nanomedicines. Not addressing the issues related to production may make the companies less interested in investing resources in this industry.

Read the original here:
What are the Upcoming Trends of Nanotechnology in Medicine? - Medical Tech Outlook

Journal of Nanomedicine and Nanotechnology- Open Access …

NLM ID: 101562615SJR H Index:16SJR 2017: 0.35ICDS 2017: 3.8

Nanomedicine is the application of nanotechnology which made its debut with greatly increased possibilities in the field of medicine. Nanomedicine desires to deliver research tools and clinically reformative devices in the near future.

Journal of Nanomedicine & Nanotechnology covers wide varieties of topics such as molecular nanotechnology, nanosensors, nanoparticles, nanodrugs, Nanomaterials, nanobiotechnology, nanobiopharmaceutics, nanoelectronics, nanorobotics, etc.. The journal includes a wide range of fields in its discipline to create a platform for the authors to make their contribution towards the journal and the editorial office promises a peer review process for the submitted manuscripts for the quality of publishing.

The journal is using Editorial Manager System for quality peer review process. Editorial Manager is an online manuscript submission, review and tracking systems. Review processing is performed by the editorial board members of Journal of Nanomedicine & Nanotechnology or outside experts; at least two independent reviewers approval followed by editor approval is required for acceptance of any citable manuscript. Authors may submit manuscripts and track their progress through the system, hopefully to publication. Reviewers can download manuscripts and submit their opinions to the editor. Editors can manage the whole submission/review/revise/publish process.

The Journal of Nanomedicine & Nanotechnology is a scientific journal which provides an opportunity to share the information among the medical scientists and researchers. The main function of open access publishing platforms is to present the content online, making it available to all, and link this information with useful scientific data.The Journal of Nanomedicine & Nanotechnology aims to publish articles bimonthly and is one of the best open access journals of scholarly publishing.

Journal of Nanomedicine & Nanotechnology is anacademic journal which aims to publish most complete and reliable source of information on the discoveries and current developments in the mode of Research articles, Review articles, Case reports, Short communications, etc. in all areas of the field and making them freely available through online without any restrictions or any other subscriptions to researchers worldwide.

You can find a clear view of peer review process by clicking here.

Material Science Research: Material Science and NanotechnoMaterials are crucial to the performance and reliability of virtually every technology and the vitality and health of any living organism. The central theme of materials science and engineering is that the process by which a material comes into being determines its structure, which in turn controls its properties and ultimately its functional performance.

Nanotechnology is the engineering of functional systems at the molecular scale. It is the study and application of extremely small things and can be used across all the other science fields, such as chemistry, biology, physics, materials science, and engineering.

Related Journals of NanotechnologyNanoscience and Nanotechnology, Nanoscience and Nanotechnology Letters, Journal of Nanomedicine & Biotherapeutic Discovery, IEEE Transactions on Nanobioscience, Journal of Biomedical Nanotechnology, Photonics and Nanostructures - Fundamentals and Applications

Nanobiotechnology is the application of nanotechnology to the life sciences: The technology encompasses precision engineering as well as electronics, and electromechanical systems as well as mainstream biomedical applications in areas as diverse as gene therapy, drug delivery and novel drug discovery techniques.

Related Journals of NanobiotechnologyJournal of Biomedical Nanotechnology, Research Journal of Nanoscience and nanotechnology, Nature Nanotechnology Journal, Nanomaterials & Molecular Nanotechnology, Nature Nanotechnology, Nano Letters, Advanced Materials, Nano Today

A Nanocomposite is a multiphase solid material where one of the phases has one, two or three dimensions of less than 100nm, or structure having nano-scale repeat distance between the different phases that make up the material.

Related Journals of Nanocomposites

Journal of Nanomaterial and Nanotechnology, International Journal of Nanotechnology Impact Factor, Journal of Nanomedicine & Biotherapeutic Discovery, Scripta Materialia, Nanoscale, Lab on a Chip - Miniaturisation for Chemistry and Biology, Materials Science & Engineering A: Structural Materials: Properties, Microstructure and Processing

The Integrated Project Nanobiopharmaceutics aims at the development of innovative multidisciplinary approaches for the design, synthesis and evaluation of functionalised nano-carriers and nano-particle-based micro-carriers for the treatment of various diseases based on targeted, controlled delivery of therapeutic peptides and proteins (biopharmaceutics).

Related Journals of NanobiopharmaceuticsJournal of Nanomedicine & Biotherapeutic Discovery, Journal of Nanobiomedical Impact Factor, Journal of Obsessive-Compulsive and Related Disorders, Journal of Homotopy and Related Structures, Journal of Venomous Animals and Toxins including Tropical Diseases

Nanoelectronics is one of the major technologies of Nanotechnology. It plays vital role in the field of engineering and electronics.

Related Journals of Nanoelectronics Journal of Nanotechnology and Electrophysics, Nano Research & Applications, ACS Applied Materials and Interfaces, International Journal of Nanotechnology Applications, Biosensors and Bioelectronics, Journal of Physical Chemistry C, Nanomedicine: Nanotechnology, Biology, and Medicine

Nanomedicine is the medical application of nanotechnology. Nanomedicine ranges from the medical applications of nanomaterials, to nanoelectronic biosensors, and even possible future applications of molecular nanotechnology.

Related Journals of Nanomedicine Nanomaterials & Molecular Nanotechnology, Pharmaceutical Nanotechnology, Journal of Biomedical Nanotechnology, International Journal of Nanomedicine, Nanomedicine: Nanotechnology, Biology and Medicine, Journal of Nanomedicine Research, European Journal of Nanomedicine

Nanotoxicology is a branch of toxicology concerned with the study of the toxicity of nanomaterials, which can be divided into those derived from combustion processes (like diesel soot), manufacturing processes (such as spray drying or grinding) and naturally occurring processes (such as volcanic eruptions or atmospheric reactions).

Related Journals of NanotoxicologyNanomedicine & Nanotechnology, Nanotechnology Journal Lists, Nano Journal Impact Factor, Microscale Thermophysical Engineering, Microelectronic Engineering, Nano Biomedicine and Engineering, Nano-Micro Letters

Nanoengineering is the practice of engineering on the nanoscale. It derives its name from the nanometre, a unit of measurement equalling one billionth of a meter. Nanoengineering is largely a synonym for nanotechnology, but emphasizes the engineering rather than the pure science aspects of the field.

Related Journals of NanoengineeringJournal of Nanoresearch, Review in Nanoscience and Nanotechnology, Nature Nanotechnology Journal, Research & Reviews: Journal of Pharmaceutics and Nanotechnology, Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology, Nanotoxicology, Precision Engineering, Nanomedicine, Nanotechnology

The spontaneous association of molecules under equilibrium conditions into stable, structurally well-defined aggregates.

Related Journals of NanofabricationsJournal of Nanotechnology Impact Factor, Nanotechnology Journal Lists, Journal of Nano, Nanomaterials & Molecular Nanotechnology, Microporous and Mesoporous Materials, International Journal of Nanomedicine, Beilstein Journal of Nanotechnology

Nanofluidics is often defined as the study and application of fluid flow in and around nanosized objects.

Related Journals of Nanofluidics Research Journal of Nanoscience and Nanotechnology, Nano Journal Impact Factor, Journal of Nanotechnology and Electrophysics, Journal of Bionanoscience, Nanotechnology, Science and Applications, Journal of Nanobiotechnology, Plasmonics, Biomedical Microdevices

Nanohedron aims to exhibit scientific images, with a focus on images depicting nanoscale objects. The work ranges from electron microscopy images of nanoscale materials to graphical renderings of molecules. Scientific images lying outside the realm of nanoscience such as algorithmic art or confocal microscopy images of cells will also be considered.

Related Journals of Nanohedron Biomicrofluidics, Nanotechnology Journal Lists, Nano Journal Impact Factor, IEEE Transactions on Nanotechnology, Microfluidics and Nanofluidics, Journal of Micromechanics and Microengineering

Nano Cars Into the robotics is new technology which is useful for designing robots. Difference in exisiting robotics and nano cars is this system works as nervous system where as in existing system stepper motors are used.

Related Journals of Nanocars Pharmaceutical Nanotechnology, Journal of Nanobiomedical Impact Factor, Review in Nanoscience and Nanotechnology,Nanomedicine & Biotherapeutic Discovery, ACS Nano, Advanced Functional Materials, Journal of Physical Chemistry Letters, Biomaterials, Small, Nano Research

Nanothermite, as the name suggests, is thermite in which the particles are so small that they are measured in nanometers is an ultra-fine-grained (UFG) variant of thermite that can be formulated to be explosive by adding gas-releasing substances.

Related Journals of NanothermiteNanoscale Research Letters, Journal of Nanobiomedical Impact Factor, International Journal of Nanoscience, Microelectronics and Reliability, Journal of Nanoparticle Research, AIP Advances

A sequence of nanoscale C60 atoms arranged in a long thin cylindrical structure. Nanotubes are extremely strong mechanically and very pure conductors of electric current. Applications of the nanotube in nanotechnology include resistors, capacitors, inductors, diodes and transistors.

Related Journals of NanotubesNanotechnology journals, Nature Nanotechnology Journal, Nano Journal Impact Factor, ACM Journal on Emerging Technologies in Computing Systems, Science of Advanced Materials, Journal of Nanophotonics

Having an organization more complex than that of a molecule.

Realated Journals of Supramolecule Plasmonics, Journal of Biomedical Nanotechnology, International Journal of Nanoscience, Journal of Nanobiomedical Impact Factor, Biomedical Microdevices, Biomicrofluidics, IEEE Transactions on Nanotechnology

Nanoionics is the study and application of phenomena, properties, effects and mechanisms of processes connected with fast ion transport (FIT) in all-solid-state nanoscale systems.

Related Journals of Nanoionics Journal of Nanoresearch, Journal of Nanoscience and Nanotechnology, Journal of Biomedical Nanotechnology, Nanomedicine, Nanotechnology, Microporous and Mesoporous Materials, International Journal of Nanomedicine

Nanolithography is the branch of nanotechnology concerned with the study and application of fabricating nanometer-scale structures, meaning patterns with at least one lateral dimension between 1 and 100 nm.

Related Journals of NanolithographyInternational Journal of Nanotechnology, Journal of Nanotechnology Impact Factor, Nanoscience and Nanotechnology Letters, Nano Research, Scripta Materialia, Nanoscale, Lab on a Chip - Miniaturisation for Chemistry and Biology

Nanoparticles are particles between 1 and 100 nanometers in size. In nanotechnology, a particle is defined as a small object that behaves as a whole unit with respect to its transport and properties. Particles are further classified according to diameter.

Related Journals of Nanoparticles Journal of Nanoscience and Nanotechnology, International Journal of Nanoscience, Journal of Nanomaterial and Nanotechnology, Journal of Nanoparticle Research, Journal of Nanoparticles, International Journal of Nanoparticles,

Exploitation of biomaterials, devices or methodologies on the nanoscale.

Related Journals of Bionanoscience Pharmaceutical Nanotechnology, Journal of Nanobiomedical Impact Factor, Journal of Biomedical Nanotechnology, Recent Patents in Nanotechnology, Journal of Bionanoscience, BioNanoScience, Nanomedicine, Nanotechnology, Microporous and Mesoporous Materials

Read this article:
Journal of Nanomedicine and Nanotechnology- Open Access ...

Laboratory of Nanomedicine and Biomaterials

GDA 2014 Honoree: Dr. Omid Farokhzad Wall Street Journal Interview Cellular Surgeons: New Era of Nanomedicine New York Academy of Sciences Event ecancertv: Polymeric Nanoparticles for Medical Applications Our Research

Nanotechnology has generated a significant impact in nearly every aspect of science. Our research seeks novel nanomaterials and nanotechnologies in order to develop advanced drug delivery systems with the promise to improve health care. Highly interdisciplinary and translational, our research is focused on multifunctional, nanoparticle-based drug delivery systems. We seek to improve nanoparticle synthesis and formulation and its therapeutic efficacy. Additionally, we develop robust engineering processes to accelerate translation of nanoparticle-based drugs into the drug development pipeline. At the same time, we emphasize a fundamental understanding of the interface between nanomaterials and biological systems. Read our recent reviews below:

See below for some of our selected research articles. Click on images for more detail:

Transepithelial transport of fc-targeted nanoparticles by the neonatal fc receptor for oral delivery:

A study on the immunocompatibility properties of lipid-polymer hybrid nanoparticles with heterogeneous surface functional groups:

Engineering of targeted nanoparticles for cancer therapy using internalizing aptamers isolated by cell-uptake selection:

Synthesis of Size-Tunable Polymeric Nanoparticles Enabled by 3D Hydrodynamic Flow Focusing in Single-Layer Microchannels:

Effects of ligands with different water solubilities on self-assembly and properties of targeted nanoparticles:

Development of poly(ethylene glycol) with observable shedding:

Congratulations to Nazila Kamaly for her appointment as an Associate Professor at Technical University of Denmark (01/01/16)

Congratulations to Jun Wu for his appointment as a Professor at Sun Yat-sen University, China (01/01/16)

Congratulations to Christian Vilos for securing the Chilean Grant (Fondecyt)! (01/30/16)

Congratulations to Naomi Morales-Medina for securing an undergraduate National Aeronautic and Space Administration (NASA) Fellowship for minorities in STEM fields! (10/19/15)

Congratulations to Christian Vilos for his promotion to Associate Professor at Center for Integrative Medicine and Innovative Science (CIMIS) in Faculty of Medicine in Andres Bello University! (09/10/15)

Congratulations to Won Il Choi for securing a Senior Researcher position at the Korea Institute of Ceramic Engineering and Technology! (09/10/15)

Congratulations to Jining Huang for getting admission in the Bioengineering PhD Program at Caltech. (03/24/15)

Welcome Dr. Sejin Son to join our team! (10/31/14)

Welcome Dr. Dmitry Shvartsman to join our team! (09/19/14)

Welcome Dr. Harshal Zope to join our team! (06/15/14)

Welcome Dr Yanlan Liu, Dr. Xiaoding Xu and Dr. Arif Islam to join our team! (03/12/14)

Welcome Dr. Basit Yameen to join our team! (09/09/2013)

Congratulations to Dr. Archana Swami for her poster prize at the MIT Polymer Day Symposium! (05/02/2013)

Welcome Dr. Mikyung Yu, Dr. In-hyun Lee, Dr. Won IL Choi, Dr. Renata Leito and Dr. Cristian Vilos to join our team! (05/02/2013)

Congratulations to Dr. Archana Swami for receiving an 'Outstanding Paper' award from the ASME at NEMB2013! (31/01/2013)

Welcome Dr. Giuseppe Palmisano to join our team! (04/01/12)

Congratulations to Steffi Sunny for securing a PhD position on the Applied Science and Engineering PhD program at Harvard University! (04/01/12)

Congratulations to Shrey Sindhwani for securing a Physician Scientist Training Program (MD-PhD) position at the University of Toronto! (04/01/12)

Congratulations to Dr. Xiaoyang Xu on the award of his National Cancer Institute funded Ruth L. Kirschstein National Research Service Award Post-doctoral Fellowship! (01/03/2012)

Congratulations to Dr. Jinjun Shi on the award of his National Cancer Institute K99/R00 Career Award! (11/30/2011)

Congratulations to Dr. Jinjun Shi for his BWH Biomedical Research Institute award! (11/10/2011)

Welcome Dr. Nazila Kamaly to join our team! (01/25/2011)

Welcome Dr. Jun Wu, Dr. Xueqing Zhang and Changwei Ji to join our team! (11/15/2010)

Welcome Dr. Suresh Gadde to join our team! (12/15/2009)

Welcome Dr. Xiaoyang Xu to join our team! (10/19/09)

Welcome Dr. Archana Mukherjee to join our team! (08/19/09)

Immunocompatibility properties of lipid-polymer hybrid nanoparticles with heterogeneous surface functional groups, Salvador-Morales C, Zhang L, Langer et al, Biomaterials, 30 (2009) 2231.

Engineering of targeted nanoparticles for cancer therapy using internalizing aptamers isolated by cell-uptake selection, Xiao Z, Levy-Nissenbaum E, Alexis F et al, ACS Nano, 6 (2012) 696.

Synthesis of size-tunable polymeric nanoparticles enabled by 3D hydrodynamic flow focusing in single-layer microchannels., Rhee M, Valencia M, Rodriguez MI et al, Advanced Materials, 23 (2011) H79.

Effects of ligands with different water solubilities on self-assembly and properties of targeted nanoparticles, Valencia PM, Hanewich-Hollatz MH, Gao W et al, Biomaterials, 23 (2011) 6226.

Poly (ethylene glycol) with Observabel Shedding, Valencia PM, Hanewich-Hollatz MH, Gao W et al, , 23 (2010) 6567.

Preclinical Development and Clinical Translation of a PSMA-Targeted Docetaxel Nanoparticle with a Differentiated Pharmacological Profile, Hrkach J, Von Hoff D, Ali MM et al, Science Translational Medicine, 4 (2012) 128ra39.

Targeted polymeric therapeutic nanoparticles: design, development and clinical translation, N Kamaly, Z Xiao, P Valencia et alChem. Soc. Rev, 41 (2012) 2971.

Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers, F. Gu, L. Zhang, B. A. Teply et alPNAS, 105 (2008) 2586.

Quantum dot-aptamer conjugates for synchronous cancer imaging, therapy, and sensing of drug delivery based on bi-fluorescence resonance energy transfer, V Bagalkot, L Zhang, E Levy-Nissenbaum et alNano Lett., 7 (2007) 3065.

Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo, O. Farokhzad, J. Cheng, B. A. Teply, et al PNAS, 103 (2006) 6315.

Original post:
Laboratory of Nanomedicine and Biomaterials

Dr. Lawrence Mayer – President and Head of Research at Celator Pharmaceuticals – Video


Dr. Lawrence Mayer - President and Head of Research at Celator Pharmaceuticals
Script: As you probably know, treatment of AML have been the same for the last 30 years; and it has not been particularly effective. You uses two drugs: cyta...

By: LLSCanada

View post:
Dr. Lawrence Mayer - President and Head of Research at Celator Pharmaceuticals - Video

New hope for leukemia patients

Kochi, Oct 15 (UNI)

Amrita Centre for Nanosciences and Molecular Medicine, part of the Amrita Institute of Medical Sciences and Research Centre has claimed to have discovered a potential cure for drug resistant leukemia.

Chronic Myeloid Leukemia (CML) responds well to a drug named 'Imatinib', however, when drug resistance sets in, which is in about 20-25 per cent of the cases, the patients has little chance of survival, a press release said here today.

Drug resistance was due to certain point mutations in the leukemia cells as a result of which the cells find an alternative pathway for survival, preventing the drug from killing the cancer cells, it said.

The Centre has developed a nanomedicine which had shown significant ability to kill the drug reststant cancer cells.

The nanomedicine was developed over the past three years and has shown success in in-vitro (or cell line based) studies, it added.

The Centre was now conducting animal trials or pre-clinical studies of the drug, it said, adding that it is expected that if pre-clinical trials are successful the new nano medicine can be submitted for clinical trial after approval from the government.

This was the first such discovery in the world of nanomedicine that effectively solves the problem of severe drug resistance in blood cancers.

The senior scientists involved in the research and development was Dr Manzoor Koyakutty, Professor and Dr Shantikumar Nair, Centre Director and Dean of Research.

Clinicians from the hospital who are involved in the research are Dr Pavithran, Dr Neeraj and Dr Prabhu. The PhD student who has worked on this as part of her PhD thesis is Archana Ratnakumari, it added.

See the original post:
New hope for leukemia patients

Deakin University – Practical Science – Nano medicine – Video


Deakin University - Practical Science - Nano medicine
http://www.deakin.edu.au An interview with Deakin University research fellow Dr Rupinder Kanwa as she discusses Deakin Uni #39;s groundbreaking Nano Medicine research Another one of many great reasons to come to Deakin University Open DayFrom:deakinuniversityViews:44 0ratingsTime:01:14More inEducation

More here:
Deakin University - Practical Science - Nano medicine - Video

NanoGuardian's On-Dose NanoEncryption Brand Protection Technology to Be Presented at AAPS Annual Meeting

SKOKIE, IL--(Marketwire - Oct 11, 2012) - NanoGuardian, a division of NanoInk, Inc. that delivers on-dose brand protection solutions to the pharmaceutical industry to fight counterfeiting and illegal diversion, announced today that it will give a poster presentation at the American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exhibition, which is being held on October 14 - 18, at McCormick Place in Chicago. The abstract, "Can Nanofabrication be used to Combat Counterfeit Medicines by Applying On-dose Authentication Features without Disrupting the Integrity of the Medicine?" will be presented on Monday, October 15, from 1:30 to 4:30 p.m. in Hall F by Bjoern Rosner, director of research and development, brand protection for NanoGuardian.

"Counterfeit medicines have become such a problem that pharmaceutical manufacturers are evaluating how to best ensure the integrity of their medicines for patients early in the drug development process," said Dean Hart, chief commercial officer of NanoGuardian. "The AAPS poster presentation will demonstrate that NanoGuardian's NanoEncryption technology can be used to incorporate highly sophisticated nanoscale, authentication, and tracing features directly on film-coated tablets, gelatin capsules, and vial caps without affecting the dissolution or stability of the medication -- important considerations in the development and commercialization of a new medication."

NanoGuardian's NanoEncryption technology is the only on-dose, multi-layered, brand protection solution that enables pharmaceutical manufacturers to authenticate and trace every single dose, from plant to patient. NanoGuardian's Closed-Loop Protection Program combines the on-dose authentication and tracing benefits of NanoEncryption technology with a proactive supply chain auditing program to identify counterfeit or illegally diverted pharmaceuticals entering the global supply chain as early as possible.

NanoGuardian fights both counterfeiting and illegal diversion with a single technology that can be used to protect capsules, tablets, vial caps, and single-use syringes providing a layered security of overt, covert, and forensic features. The overt and covert security features allow dose-level authentication at any point in the supply chain, while the forensic and nano-scale NanoCodes provide comprehensive tracing information on each and every dose. NanoGuardian's technology provides a strong benefit over other on-dose technologies given that NanoGuardian's security features are implemented with no additional material or chemicals being added to the medication.

As evidence of the rapidly growing problem of counterfeit pharmaceuticals, a recent report from the U.S. Customs and Border Protection and the U.S. Immigration and Customs Enforcement noted that the domestic value of counterfeit pharmaceutical seizures in fiscal year 2011 rose by more than $11 million, an increase of almost 200 percent. The implications for victims of counterfeit drugs are extremely serious, often resulting in unexpected side effects, severe allergic reactions and even death.

AAPS provides a dynamic international forum for the exchange of knowledge among scientists to enhance their contributions to health. It offers timely scientific programs, ongoing education, opportunities for networking, and professional development. More information is available at: http://www.aaps.org.

About NanoGuardian NanoGuardian, a division of NanoInk, Inc., focuses exclusively on delivering brand protection solutions to fight illegal diversion and counterfeiting. Anchored by NanoInk's novel NanoEncryption technology, NanoGuardian enables manufacturers to authenticate and trace the integrity of their products across the supply chain. More information about NanoGuardian is available at http://www.nanoguardian.net.

NanoInk, NanoGuardian, NanoEncryption and the NanoGuardian logo are trademarks or registered trademarks of NanoInk, Inc.

Go here to read the rest:
NanoGuardian's On-Dose NanoEncryption Brand Protection Technology to Be Presented at AAPS Annual Meeting

How 3D Printers Are Reshaping Medicine

Printing off a kidney or another human organ may sound like something out of a science fiction novel, but with the advancements in 3D printing technology, the idea may not be so far-fetched.

BioprintingWhile 3D printing has been successfully used in the health care sector to make prosthetic limbs, custom hearing aids and dental fixtures, the technology is now being used to create more complex structures - particularly human tissue.

Organovo (onvo), a San Diego-based company that focuses on regenerative medicine, is one company using 3D printers, called bioprinters, to print functional human tissue for medical research and regenerative therapies.

"This is disruptive technology," said Mike Renard, Organovo's vice president of commercial operations. "It's always interesting and fun, but never easy."

(More From CNBC: 15 Surprising Global Technology Cities)

Traditional 3D printing, also known as additive manufacturing, is a process of making three dimensional solid objects from a digital model. 3D printing is achieved using additive processes, in which an object is created by laying down successive layers of material such as plastic, ceramics, glass or metal to print an object. Companies including Boeing (ba), General Electric (ge) and Honeywell (hon) use this type of 3D printing to manufacture parts.

Bioprinters, though, use a "bio-ink" made of living cell mixtures to form human tissue. Basically, the bio-ink is used to build a 3D structure of cells, layer by layer, to form tissue.

Eventually, medical researchers hope to be able to use the printed tissue to make organs for organ replacement.

However, growing functional organs is still at least 10 years away, said Shaochen Chen, a professor of nano-engineering at the University of California, San Diego, who uses bioprinting in researching regenerative medicine.

But even though developing functional organs may still be a decade off, medical researchers and others are using bioprinting technology to make advancements in other ways.

Excerpt from:
How 3D Printers Are Reshaping Medicine

Delivering an integral approach to emotional and mental health

Dr. Frank Maye, DOM (NMD)

When talking about an integral approach to emotional health, the term integral is not integrative or complimentary. Integral is not a mainstream approach. Integral simply implies that a team concept is adopted, and the team agrees to use whatever strategies work best for the patient. Patients benefit from a variety of disciplines which all work with one another. I believe these techniques are the future of all medical practice. I returned to school to obtain a PhD degree in Integral Health to ensure this approach took root in Miami.

Emotional and mental health includes a spectrum of conditions, including autism, obsessive compulsive disorder, eating disorders, ADD/ADHD, addictions, depression and anxiety. Some conditions require pharmacology and others call for counseling or talk-therapy. However, there is another alternative. Are you aware that there are nutritional causes of emotional and mental discomfort? You may ask how do I determine if these factors apply to me? There are tests available to help determine bacterial, nutritional, food allergies and toxicity, which are all causative factors. Even if you are already taking an anti-depressant or anxiety-relieving drug, you can I still benefit from these tests. Many side effects are minimized when the causative factors are identified.

At Maye Holistic Med, I spend two hours with every new patient. I ask myself Where did this patient lose their way? ! I owe this time to you and this question helps me guide you emotionally, physically and spiritually back to starting life over. The day you give up on your passion and dreams, the emotional, physical and spiritual you become depressed. The simple tests I conduct reveal and confirm how much this has affected you. Then, I can work to get you happy to be you again.

Psychiatrists, psychologists and natural healthcare providers can work as a team. Recently I attended a conference with 120 other physicians for the Integration of Mental Healthcare Teams. We all agreed that patient-centered healthcare is integral care. We band together as a team to deliver therapies that our patients need to get healthy and happy.

Join me at Maye Holistic Med as a patient or cooperating physician. Sometimes the answer to your problems is simple and sometimes it is complex. Let me help you put a team together.

Dr. Frank Maye, DOM (NMD) is a Diplomate of Naturopathic Medicine and a Diplomate of Acupuncture and Oriental Medicine. Maye graduated from Community School of Traditional Chinese Healthcare, Inc. Dr. Maye continued his studies at American Naturopathic Medical Institute where he was awarded a Doctorate in Naturopathic Medicine and a designation of (NMD). Along with his private practice, Dr. Maye currently researches for Scintilla Software Industries in the field of Bio-energetics, Resonance Homeopathy, and Nutritional Nano technology.

Dr. Maye can be reached at 305-668-9555 or email:mayeholisticmed@aol.com. Visit us at: mayeholisticmed.com

Short URL: http://www.communitynewspapers.com/?p=47396

Visit link:
Delivering an integral approach to emotional and mental health

Regenerative Medicine Biotech Company, Eqalix, Names Scientific Advisory Board

Eqalix Inc., an emerging regenerative medicine company, announces its Scientific Advisory Board (SAB). This SAB gives Eqalix a depth and breadth of experience necessary to take it to the next level.

Reston, VA (PRWEB) October 09, 2012

"We are very pleased to bring together these key thought leaders to establish the Eqalix Scientific Advisory Board," stated Joseph P. Connell, Eqalix CEO and Chairman of the Board. "I have worked with Drs. Gold and Goldman for years and have always admired their abilities. Dr Lelkes technologies will make a profound impact upon aesthetic dermatology, wound healing and regenerating blood vessels, nerve endings and damaged organs with the guidance of this distinguished panel. It is not clich in any manner when I say that we are thrilled to work with this team. We look to their guidance, industry knowledge and network to help deliver these therapies into clinic and prospective patients as soon as possible, as I am confident our technologies will make a difference, said Connell.

The members of the Eqalix Scientific Advisory Board are:

Peter I. Lelkes, PhD: Chief Scientific Advisor; Dr. Lelkes is the Laura H. Carnell Professor and Founding Chair of the Department of Bioengineering in the College of Engineering at Temple University and the Inaugural Director of the Institute for Regenerative Medicine and Engineering (TIME) at Temple Universitys School of Medicine. While at Drexel, Prof. Lelkes directed an interdisciplinary program in tissue engineering and regenerative medicine, focusing on nanotechnology-based biomaterials and soft tissue engineering, employing developmental biological principles to enhance the tissue-specific differentiation of embryonic and adult stem cells. Dr. Lelkes has organized several Keystone conferences and published more than 160 peer-reviewed papers and 45 book chapters and made more than 400 presentations nationally and internationally.

Dr. Lelkes basic and translational research has been support by federal (NIH, NSF, NASA, DOE) and state funding agencies, (NTI and Dept. of Commerce, Tobacco Settlement Funds) and private Foundations, including the Coulter Foundation. Most recently, Dr. Lelkes has been named Director of the Surgical Engineering Enterprise, one of the major initiatives of the strategic plan of Drexel Universitys College of Medicine. In addition, Dr. Lelkes has been the team leader for tissue engineering at the Nanotechnology Institute of Southeastern Pennsylvania (NTI) and is the Co-Director of PATRIC, the Pennsylvania Advanced Textile Research and Innovation Center, focusing on BioNanoTextiles and Stem Cell Biology.

Dr Lelkes stated, "I am delighted and excited to partner with Eqalix to translate our inventions from the bench to the bedside in a timely fashion.

Mitchel P. Goldman, MD, Scientific Advisor, Founder and Medical Director of Goldman Butterwick Fitzpatrick, Groff & Fabi, Cosmetic Laser Dermatology. A graduate of Boston University, Summa Cum Laude, and the Stanford University Medical School, Dr. Goldman is a Volunteer Clinical Professor in Medicine/Dermatology at the University of California, San Diego. Dr Goldman is Board Certified by both the American Board of Dermatology and the American Board of Cosmetic Surgery.

He is a fellow of the American Academy of Dermatology, American Society for Dermatologic Surgery, American Society for Laser Medicine and Surgery, American Academy of Cosmetic Surgery and the American Society of Liposuction Surgery. He is former President of the American College of Phlebology and President-Elect of the American Society for Dermatologic Surgery. He presently serves on the Board of Trustees for the American Academy of Cosmetic Surgery. He also has authored and/or co-authored 21 Textbooks on Dermatology, Sclerotherapy, Ambulatory Phlebectomy, Cutaneous Laser Surgery, Cellulite and Dermatologic Surgery as well as over 300 peer-reviewed publications and textbook chapters.

Dr Goldman added: I am very interested and excited to work with the Eqalix team to make these technologies a success. I believe that my background lends well to truly shaping the successful commercialization of these products for my patients to improve outcomes.

See original here:
Regenerative Medicine Biotech Company, Eqalix, Names Scientific Advisory Board